Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSB | P07858 | 1/20 | 0.31 |
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
| ▸ | KDM5A | P29375 | 1/20 | 0.30 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL47613 | 0.89 | CHRM2 (0.36) | CTSBCTSSCTSK | |
| SCHEMBL47612 | 0.89 | CHRM2 (0.36) | CTSBCTSSCTSK | |
| SCHEMBL47607 | 0.87 | SIGMAR1 (0.40) | CTSBCTSSCTSK | |
| SCHEMBL47637 | 0.87 | SIGMAR1 (0.40) | CTSBCTSSCTSK | |
| SCHEMBL47642 | 0.83 | KMT2A (0.35) | CTSBCTSSCTSK | |
| SCHEMBL47611 | 0.83 | KMT2A (0.35) | CTSBCTSSCTSK | |
| SCHEMBL18566580 | 0.81 | ADORA1 (0.36) | CTSBCTSSCTSK | |
| SCHEMBL99323 | 0.81 | ADORA1 (0.36) | CTSBCTSSCTSK | |
| SCHEMBL47599 | 0.81 | ADORA1 (0.36) | CTSBCTSSCTSK | |
| SCHEMBL47603 | 0.81 | ADORA1 (0.36) | CTSBCTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120322721-A1 | DRY GROWTH HORMONE COMPOSITION TRANSIENTLY LINKED TO A POLYMER CARRIER | ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S (DK) | 2012-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120322721-A1 | DRY GROWTH HORMONE COMPOSITION TRANSIENTLY LINKED TO A POLYMER CARRIER | GHRHR, GHSR, GCG | CTSB 846/4885CTSS 1522/4885CTSK 666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.